VISANNE 2MG TAB

Visanne 2mg tablets contain dienogest, a selective progestin specifically developed for endometriosis management. Each tablet delivers 2mg of the active ingredient, providing targeted hormonal modulation to suppress endometrial proliferation and reduce associated pain symptoms. Dienogest demonstrates unique pharmacological properties with high selectivity for progesterone receptors, enabling effective disease control with minimal systemic hormonal effects. This formulation is particularly advantageous for patients seeking continuous endometriosis treatment without estrogen-containing components. Visanne tablets offer convenient daily oral administration with consistent absorption and predictable pharmacokinetics. Clinical evidence supports significant reduction in dysmenorrhea, dyspareunia, and pelvic pain associated with endometriosis. Regular gynecological monitoring and assessment of treatment efficacy ensures optimal therapeutic outcomes. Discuss contraindications and potential side effects with your healthcare provider to determine suitability for your individual clinical situation.